It might be that Ki-67 is not a deciding factor in EPC tumour progression or aggressiveness as in other cancer types such as breast cancer and neuroendocrine carcinomas of the digestive system where it is part of the routine diagnostic work-up [33]. This evidence concerns the gene MKI67 and breast carcinoma.